|
Product Details:
|
| Product Name: | Compound 7P | Other Name: | Acetamide, 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)- |
|---|---|---|---|
| CAS No: | 1890208-58-8 | MF: | C22H23N3O5S |
| MW: | 441.5 | Purity: | 99% Min |
| Shelf Life: | 2 Years | Application: | Pharmaceutical API |
| Sample: | Available | Storage: | Cool And Dry Place |
| High Light: | CAS 1890208-58-8 Compound 7p Nootropic,CAS 1890208-58-8 Nootropics Powder,CAS 1890208-58-8 Pharmaceutical API |
||
Pharmaceutical Smart Drug Nootropics Powder CAS 1890208-58-8 Compound 7P
Product Introduction
| Name | Compound 7P |
| English synonyms | Acetamide, 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)- |
| CAS Number | 1890208-58-8 |
| Molecular formula | C22H23N3O5S |
| Molecular weight | 441.5 |
| EINECS number | / |
Product Description
| Melting point | / |
| Specific Rotation | / |
| Optical Activity | / |
| Boiling point | / |
| Density | 1.329±0.06 g/cm3(Predicted) |
| Refractive Index | / |
| Solubility | / |
| Storage | / |
| Acidity coefficient (pKa) | 11?+-.0.70(Predicted) |
| Color | White to off-white |
Product Function
Compound 7p was developed as one in series of compounds with the aim of identifying dual-acting thromboxane receptor antagonist/synthase inhibitors . In fact compound 7p shows selectivity for prostaglandin I2 synthase (PTGIS , CYP8A1) over thromboxane synthase (CYP5A1).Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.
Contact Person: Mrs. Angie Zhang
Tel: +8613627115097
Fax: 86-27-5970-7018
